Tandem Investment Advisors Inc. Has $4.33 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tandem Investment Advisors Inc. reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,738 shares of the medical equipment provider’s stock after selling 1,216 shares during the period. Tandem Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $4,328,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also added to or reduced their stakes in the company. Atala Financial Inc bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $25,000. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $26,000. Global Financial Private Client LLC raised its holdings in Intuitive Surgical by 253.3% in the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 38 shares during the last quarter. Hurley Capital LLC bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $28,000. Finally, Summit Securities Group LLC bought a new position in Intuitive Surgical in the 4th quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Gary Loeb sold 1,700 shares of the business’s stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the completion of the transaction, the executive vice president directly owned 2,245 shares in the company, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director owned 6,371 shares of the company’s stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 4,998 shares of company stock valued at $2,611,577 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $540.60 on Thursday. The firm has a market cap of $193.76 billion, a PE ratio of 79.27, a PEG ratio of 5.71 and a beta of 1.64. The stock’s fifty day moving average price is $535.82 and its two-hundred day moving average price is $536.76. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the previous year, the company posted $1.50 earnings per share. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on ISRG. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Barclays lowered their price target on shares of Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Royal Bank Of Canada lowered their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Finally, Robert W. Baird lowered their price target on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.